Bajaj Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
305.55
1.1 (0.36%)
BSENSE

May 22

BSE+NSE Vol: 80.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 12.61% vs 14.61% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is -60.08% vs 147.14% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 27.16% vs 8.08% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -20.32% vs -6.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Bajaj Healthcare With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
611.03
93.99
517.04
550.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
611.03
93.99
517.04
550.10%
Raw Material Cost
306.20
0.00
306.20
Purchase of Finished goods
0.00
41.29
-41.29
-100.00%
(Increase) / Decrease In Stocks
10.20
-0.63
10.83
1,719.05%
Employee Cost
62.75
8.54
54.21
634.78%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
127.07
15.07
112.00
743.20%
Total Expenditure (Excl Depreciation)
506.21
64.27
441.94
687.63%
Operating Profit (PBDIT) excl Other Income
104.82
29.72
75.10
252.69%
Other Income
7.13
6.84
0.29
4.24%
Operating Profit (PBDIT)
111.95
36.56
75.39
206.21%
Interest
22.23
0.58
21.65
3,732.76%
Exceptional Items
-38.79
0.00
-38.79
Gross Profit (PBDT)
56.47
35.98
20.49
56.95%
Depreciation
27.55
2.75
24.80
901.82%
Profit Before Tax
28.92
33.23
-4.31
-12.97%
Tax
7.61
8.52
-0.91
-10.68%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
21.31
24.71
-3.40
-13.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
-5.54
0.00
-5.54
Net Profit
15.77
24.71
-8.94
-36.18%
Equity Capital
16.83
11.78
5.05
42.87%
Face Value
5.00
10.00
0.00
Reserves
516.17
313.93
202.24
64.42%
Earnings per share (EPS)
4.69
20.98
-16.29
-77.65%
Diluted Earnings per share
670.25
20.96
649.29
3,097.76%
Operating Profit Margin (Excl OI)
17.15%
31.62%
0.00
-14.47%
Gross Profit Margin
9.24%
38.28%
0.00
-29.04%
PAT Margin
3.49%
26.29%
0.00
-22.80%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 611.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.61% vs 14.61% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 15.77 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -60.08% vs 147.14% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 104.82 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.16% vs 8.08% in Mar 2025

Annual - Interest
Interest 22.23 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -20.32% vs -6.00% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.15%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025